Three patient deaths, 31 injuries and 322 complaints led to an FDA Class 1 recall of Teleflex/Arrow International intra-aortic balloon pump catheter kits.

Matthew Reynolds, MD, Lahey Hospital and Medical Center, explains data from the EXCALIBER and CAMELOT studies that show ambulatory cardiac monitoring usage among more than 300,000 patients.

A JACC report card highlights excess cardiovascular mortality among Black Americans and "persistent and tragic inequities" in cardiovascular care.

Delaying TAVR in eligible patients with severe AS can lead to much higher healthcare costs, according to a new study of real-world Medicare data.

Vivek Reddy, MD, was involved in most of the late-breaking pulsed field ablation trials at Heart Rhythm 2024. He spoke to Cardiovascular Business at the conference about those trials and what they mean going forward.

“While the use of cannabis continues to gain popularity, its broader effects on public health within the general population are not yet fully understood,” one researcher said.

Elutia, formerly known as Aziyo Biologics, is already targeting additional uses for the newly approved device. 

Gene manipulation can revert the cardiomyocytes back to a fetal state, allowing them to regenerate. Researchers are now looking for drugs to mimic the effect.

Early detection of cardiac amyloidosis is leads to the best outcomes, but it is often missed until later stages. AI is being developed to help detect these patients earlier using ECG and echo.

Cardiovascular Associates of America, backed by Webster Equity Partners, currently includes practices in eight different states. Its partner cardiologists now have preferred access to multiple cloud-based services provided by Athenahealth.